PortfoliosLab logo
SMMT vs. PHM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SMMT and PHM is 0.51, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

SMMT vs. PHM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Summit Therapeutics Inc. (SMMT) and PulteGroup, Inc. (PHM). The values are adjusted to include any dividend payments, if applicable.

100.00%200.00%300.00%400.00%500.00%600.00%December2025FebruaryMarchAprilMay
141.90%
430.69%
SMMT
PHM

Key characteristics

Sharpe Ratio

SMMT:

1.34

PHM:

-0.30

Sortino Ratio

SMMT:

4.89

PHM:

-0.28

Omega Ratio

SMMT:

1.66

PHM:

0.97

Calmar Ratio

SMMT:

5.31

PHM:

-0.30

Martin Ratio

SMMT:

14.21

PHM:

-0.60

Ulcer Index

SMMT:

31.77%

PHM:

19.19%

Daily Std Dev

SMMT:

299.45%

PHM:

34.09%

Max Drawdown

SMMT:

-95.75%

PHM:

-92.40%

Current Drawdown

SMMT:

-32.83%

PHM:

-30.37%

Fundamentals

Market Cap

SMMT:

$17.42B

PHM:

$20.78B

EPS

SMMT:

-$0.31

PHM:

$14.16

PEG Ratio

SMMT:

0.00

PHM:

0.31

PS Ratio

SMMT:

753.90

PHM:

1.16

PB Ratio

SMMT:

60.43

PHM:

1.70

Total Revenue (TTM)

SMMT:

$0.00

PHM:

$17.89B

Gross Profit (TTM)

SMMT:

-$40.00K

PHM:

$5.22B

EBITDA (TTM)

SMMT:

-$172.32M

PHM:

$3.96B

Returns By Period

In the year-to-date period, SMMT achieves a 38.13% return, which is significantly higher than PHM's -4.89% return. Over the past 10 years, SMMT has underperformed PHM with an annualized return of 8.78%, while PHM has yielded a comparatively higher 19.72% annualized return.


SMMT

YTD

38.13%

1M

48.14%

6M

16.82%

1Y

396.98%

5Y*

48.72%

10Y*

8.78%

PHM

YTD

-4.89%

1M

12.32%

6M

-20.88%

1Y

-10.09%

5Y*

29.63%

10Y*

19.72%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SMMT vs. PHM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SMMT
The Risk-Adjusted Performance Rank of SMMT is 9797
Overall Rank
The Sharpe Ratio Rank of SMMT is 9090
Sharpe Ratio Rank
The Sortino Ratio Rank of SMMT is 9999
Sortino Ratio Rank
The Omega Ratio Rank of SMMT is 9898
Omega Ratio Rank
The Calmar Ratio Rank of SMMT is 9999
Calmar Ratio Rank
The Martin Ratio Rank of SMMT is 9797
Martin Ratio Rank

PHM
The Risk-Adjusted Performance Rank of PHM is 3434
Overall Rank
The Sharpe Ratio Rank of PHM is 3535
Sharpe Ratio Rank
The Sortino Ratio Rank of PHM is 2929
Sortino Ratio Rank
The Omega Ratio Rank of PHM is 3131
Omega Ratio Rank
The Calmar Ratio Rank of PHM is 3333
Calmar Ratio Rank
The Martin Ratio Rank of PHM is 4040
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SMMT vs. PHM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Summit Therapeutics Inc. (SMMT) and PulteGroup, Inc. (PHM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current SMMT Sharpe Ratio is 1.34, which is higher than the PHM Sharpe Ratio of -0.30. The chart below compares the historical Sharpe Ratios of SMMT and PHM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00December2025FebruaryMarchAprilMay
1.34
-0.30
SMMT
PHM

Dividends

SMMT vs. PHM - Dividend Comparison

SMMT has not paid dividends to shareholders, while PHM's dividend yield for the trailing twelve months is around 0.81%.


TTM20242023202220212020201920182017201620152014
SMMT
Summit Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PHM
PulteGroup, Inc.
0.81%0.75%0.66%1.34%1.00%1.16%1.16%1.46%1.08%1.96%1.85%1.07%

Drawdowns

SMMT vs. PHM - Drawdown Comparison

The maximum SMMT drawdown since its inception was -95.75%, roughly equal to the maximum PHM drawdown of -92.40%. Use the drawdown chart below to compare losses from any high point for SMMT and PHM. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2025FebruaryMarchAprilMay
-32.83%
-30.37%
SMMT
PHM

Volatility

SMMT vs. PHM - Volatility Comparison

Summit Therapeutics Inc. (SMMT) has a higher volatility of 60.73% compared to PulteGroup, Inc. (PHM) at 12.16%. This indicates that SMMT's price experiences larger fluctuations and is considered to be riskier than PHM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%60.00%December2025FebruaryMarchAprilMay
60.73%
12.16%
SMMT
PHM

Financials

SMMT vs. PHM - Financials Comparison

This section allows you to compare key financial metrics between Summit Therapeutics Inc. and PulteGroup, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00BJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250
3.89B
(SMMT) Total Revenue
(PHM) Total Revenue
Values in USD except per share items